Australia - English - Department of Health (Therapeutic Goods Administration)

trucell pty ltd - 35719 - picture archiving and communication system, radiology - infinitt pacs is a picture archive and communication system designed for storage, retrieval and transmission of digital images. it does not contain controls for direct operation of any image acquisition systems.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - brucella melitensis (unii: oqf85710lz) (brucella melitensis - unii:oqf85710lz) - brucella melitensis 11 [hp_c] in 1 ml - for temporary relief of symptoms related to brucella infection including fever, sweats, malaise, headache, back pain, neck pain, malodorous sweat, peculiar taste in mouth, and gut inflammation.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to brucella infection including fever, sweats, malaise, headache, back pain, neck pain, malodorous sweat, peculiar taste in mouth, and gut inflammation.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

deseret biologicals - brucella melitensis (unii: oqf85710lz) (brucella melitensis - unii:oqf85710lz) - brucella melitensis 11 [hp_c] in 1 ml - for temporary relief of symptoms related to brucella infection including chronic fatigue syndrome, fibromyalgia, fever, sweats, malaise, anorexia, headache, back pain, neck pain, malodorous sweat, peculiar taste in mouth, and gut inflammation.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to brucella infection including chronic fatigue syndrome, fibromyalgia, fever, sweats, malaise, anorexia, headache, back pain, neck pain, malodorous sweat, peculiar taste in mouth, and gut inflammation.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

Australia - English - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - ct780 - brucella ivds - for in vitro diagnostic use in testing clinical specimens for antibodies to brucella bacteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

abacus dx pty ltd - ct780 - brucella ivds - to be used in testing to provide information about infection with or exposure to brucella bacteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

esl biosciences australia 2012 pty ltd - ct780 - brucella ivds - ivds that are intended to be used in testing to provide information about infection with or exposure to brucella bacteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

biomerieux australia pty ltd - ct780 - brucella ivds - ivds intended to be used in testing to provide information about infection with or exposure to brucella bacteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

dksh australia pty ltd - ct780 - brucella ivds - immunserological in vitro diagnostic medical devices to be used in infectious disease diagnostics.

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

hester biosciences limited, india - brucella rb - cake - 1

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - doxycycline hyclate, quantity: 115.4 mg (equivalent: doxycycline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; maize starch; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; indigo carmine; macrogol 4000 - other conditions: protect from moisture. indications: infections caused by the following organisms; mycoplasma pneumoniae (primary atypical pneumonia); rickettsiae (queensland tick typhus, epidemic typhus fever, q fever, murine endemic typhus fever, australo-pacific endemic scrub typhus); chlamydia psittaci (psittacosis); chlamydia trachomatis (lymphogranuloma venereum, trachoma, inclusion conjunctivitis). (doxycycline is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doxycycline alone, or in combination with topical agents). borreliae (relapsing fever). calymmatobacterium (donovania) granulomatis (granuloma inguinale). infections caused by the following gram- negative microorganisms: vibrio species (chlorea), brucella sp. (brucellosis; in conjuction with streptomycin), haemophilus ducreyi (chancroid), yersinia pestis (plague), francisella turarenis (tularaemia), bartonella bacilliformis (bartonellosis), bacteroides sp. when penicillin is contraindicated, doxy-100 is an alternative drug in the treatment of infections due to: treponema pallidum (syphilis); treponema pertenue (yaws); neisseria gonorrhoea (see dosage and administration). doxy-100 is not the drug of choice in the treatment of any type of staphylococcal infection or infections due to streptococcus pneumoniae, haemophilus infuenzae, streptococcus pyogenes, streptococcus faecalis or any type of enteric bacteria because many strains of these organisms have been shown to be resistant to doxycycline. doxy-100 should not be used in these infections unless the organism has been shown to be sensitive. for upper respiratory infections due to group a beta-haemolytic streptococci (including prophylaxis of rheumatic fever), penicillin is the usual drug of choice. in acute intestinal amoebiasis, doxycycline may be a useful adjunct to amoebicides. in severe acne, doxycycline may be useful adjunctive therapy. doxycycline is indicated, in adults and children older than 10 years, as chemoprophylaxis for malaria caused by plasmodium falciparum and, in combination with other antimalarial agents, against malaria caused by plasmodium vivax. doxycycline is only able to suppress malaria caused by p. vivax. as there are relatively few locations where p. vivax does not co-exist to some extent with p. falciparum, it is recommended that doxycycline should be used routinely with other agents, for example, chloroquine.